What You Should Know:– AppliedVR, a leader in immersive therapeutic solutions, has announced the launch of their flagship product, RelieVRx®, into the workers’ compensation market. This FDA-authorized virtual reality (VR) program is the first of its kind to offer comprehensive, non-pharmacological treatment for chronic lower back pain (CLBP– AppliedVR’s RelieVRx® program signifies a significant advancement in pain management for workers’ compensation claims.A Non-Pharmacological Approach to Pain ManagementRelieVRx® stands out as the first comprehensive, immersive VR treatment specifically designed to address CLBP in workers’ compensation cases. This non-pharmaceutical pain therapy provides a cost-effective and convenient option for injured workers.The RelieVRx device provides a safe and effective alternative to traditional pain management methods. Here’s what makes it unique:Immersive VR Experience: Patients learn valuable skills through a fully immersive VR experience, empowering them to actively manage and reduce their pain.Patients learn valuable skills through a fully immersive VR experience, empowering them to actively manage and reduce their pain. Cost-Effective and Non-Pharmacological: RelieVRx offers a cost-effective solution without the use of medications, potentially reducing long-term healthcare costs.RelieVRx offers a cost-effective solution without the use of medications, potentially reducing long-term healthcare costs. Clinically Proven Results: Studies have shown that RelieVRx leads to clinically significant reductions in pain intensity and its impact on daily activities, sleep, mood, and stress

AppliedVR, a pioneer in immersive therapeutics advancing a novel approach to medicine, has launched its flagship RelieVRx(R) prescription therapeutic into workers' compensation.

AppliedVR launches RelieVRx for workers' compensation. The first FDA-authorized virtual reality prescription therapeutic for chronic lower back pain, RelieVRx provides a fully immersive VR experience to help injured workers learn skills to reduce & manage their CLBP. Extensive research shows the home-based, self-administered program produces clinically meaningful reductions in both pain intensity and pain interference with sleep and activities. Developed by pain specialists led by Stanford's Beth Darnall, PhD, the program incorporates validated principles of cognitive behavioral therapy, biofeedback and emotional regulation. See https://www.relievrx.com/workers-comp. (Photo: Business Wire)AppliedVR launches RelieVRx for workers' compensation